Institution statistics

TRANSGENE SA - France 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 9
As coordinator: 2
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0.29*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 10.999.316 0 1
2018 0 3.942.861 0 1
2015 0 18.200.000 0 1
2012 1.992.214 0 570.009 1
2008 0 2.848.153 316.461 1
2006 0 12.000.000 279.070 1
2005 2.411.006 0 241.101 1
2001 0 2.999.997 230.769 1
2000 0 1.926.405 214.045 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
MEDIZINISCHE HOCHSCHULE HANNOVER3
UNIVERSITY OF COPENHAGEN3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTE2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MEDICAL RESEARCH COUNCIL2
ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE2
UNIVERSITAET BASEL2
UNIVERSITAETSKLINIKUM JENA2
UNIVERSITE DE LAUSANNE2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT TWENTE2
UNIVERSITY COLLEGE LONDON2
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACIES SAS1
AERAS GLOBAL TB VACCINE FOUNDATION1
ANTIGONE1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTON UNIVERSITY1
ASTRAZENECA1
AVENTIS PASTEUR1
AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO PAOLO GIACCONE DI PALERMO1
Bangor University1
BIOALLIANCE PHARMA1
BIORELIANCE1
BIOSCI CONSULTING BVBA1
BLUEBIRD BIO INC1
BUNDESINSTITUT FUER RISIKOBEWERTUNG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CANCER RESEARCH UK1
CELLGENIX TECHNOLOGIE TRANSFER1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
CLEAN CELLS1
COBRA THERAPEUTICS1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
COVANCE LABORATORIES1
DELSITECH1
DEPARTMENT OF HEALTH1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DYNAMIC421
ECBIO INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA S A1
ECOLE NORMALE SUPERIEURE DE CACHAN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EDUCATIONAL FOUNDATION YONSEI UNIVERSITY1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
EPIXIS1
F HOFFMANNLA ROCHE1
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR1
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO1
FONDAZIONE TELETHON1
FORSCHUNGSZENTRUM JULICH1
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE1
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT1
FUDAN UNIVERSITY SHANGHAI CANCER CENTER1
FUNDACIO INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL1
GENETHON1
GENOSAFE SAS1
GLAXOSMITHKLINE BIOLOGICALS1
GoeTEBORG UNIVERSITY1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HOSPICES CANTONAUX CHUV1
HUNTINGDON LIFE SCIENCES1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT CATALA D'ONCOLOGIA1
INSTITUT DE RECHERCHES SERVIER1
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE1
INSTITUT PASTEUR1
INSTITUT PASTEUR DE LILLE1
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO1
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY1
INTERNATIONAL TUBERCULOSIS RESEARCH CENTER1
ISTITUTO NAZIONALE MALATTIE INFETTIVE LSPALLANZANI IRCCS1
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI1
ISTITUTO SUPERIORE DI SANITA1
JDRF INTERNATIONAL1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET ZU KOELN1
KWAZULU NATAL RESEARCH INSTITUTE FOR TBHIV NPC1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE1
LUNDS UNIVERSITET1
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MAYO CLINIC ROCHESTER1
MEDIZINISCHE UNIVERSITAET INNSBRUCK1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MILTENYI BIOTEC1
NEWLAB S A R L1
NOVARTIS PHARMA1
ONCOTEST1
Constancy:

Total number of partners:173

Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 164

Frequent / Rare Partner Ratio: 0.05

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES5
SOCIAL AND ECONOMIC CONCERNS3
RTD HORIZONTAL TOPICS2
PROTECTING MAN AND HIS ENVIRON2

Project overview:

Start dateProjectacronymrolefundingpartners
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2015-01-01TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development TBVAC2020participant18.200.00044
2012-01-01Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China IMMUNOCANcoordinator1.992.2145
2008-01-01Discovery of novel cancer serum biomarkers based on aberrant post translational modifications of O-glycoproteins (O-PTM-Biomarkers) and their application to early detection of cancer O-PTM-BIOMARKERSparticipant2.848.1539
2006-04-01European network for the advancement of clinical gene transfer and therapy CLINIGENEparticipant12.000.00043
2005-12-01Optimised and novel oncolytic adenoviruses and pox viruses in the treatment of cancer: Virotherapy combined with molecular chemotherapy THERADPOXcoordinator2.411.00610
2001-11-01European vaccine effort against hiv/aids - ii EUROVAC-IIparticipant2.999.99713
2000-01-01Development of a cancer vaccine combining dna and specific glycoprotein/glycopeptide formulations of a tumour antigen CANCER VACCINEparticipant1.926.4059

Alias institution names:
  • TRANSGENE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum